Navigation Links
Medical research on ice
Date:6/12/2008

New medical equipment recently delivered to the Antarctic station Concordia will help understand how our bodies physically adapt to this extreme environment - knowledge which could help prepare for a future human mission to Mars. ESA is currently looking for a candidate with a medical background to support projects at the research base.

The Antarctic station Concordia is located in one of the most hostile environments on the Earth. Built on an ice plateau at 3 200 m altitude, exposed to extreme isolation, temperatures, constant light in summer, constant darkness in winter and other stressors, a stay at Concordia is a huge challenge.

Harsh winter

For the up to 16 crewmembers that can be hosted in the station during the Antarctic winter, conditions are even more severe as the harsh environmental conditions make access to or from the station impossible. Any problems that occur need to be dealt with autonomously by the crew with the resources at hand.

Fortunately for ESA, many of the same constraints that naturally occur during the winter at Concordia are quite similar to those that can be expected for future crewed exploration missions, for example to Mars.

For this reason, in 2002, ESA established a cooperation with the builders and operators of the station; the French Polar Institute (Institute Paul Emile Victor, IPEV) and the Italian Antarctic Programme (Consorzio per l'Attuazione del Programma Nazionale di Ricerche in Antartide, PNRA S.C.r.l.). Next to some technology validation, the main focus of this cooperation is on medicine, physiology and psychology.

Long-Term Medical Survey

Together with the Concordia partners and a diverse group of experts, ESA has defined the Long-Term Medical Survey (LTMS); a list of physiological and psychological parameters that is collected by each Concordia crewmember, with the goal of enhancing knowledge about human adaptation in this extreme environment.

To facilitate the collection of physiological data, ESA commissioned the development of an easy-to-use, minimally intrusive, integrated monitoring device, taking into account that the majority of Concordia crewmembers have no medical background. The first prototype was recently shipped to Antarctica and is now being evaluated by the Concordia crew.

Other interesting medical and psychological research is still ongoing at the station. For example, a current project investigates how blood clotting is affected by the high altitude at Concordia. This research is very relevant to understanding the 'economy class syndrome' - the risk of thrombosis when flying long-distance in airplanes. The psychological projects look for example at how the crew adapts to the extreme environment, or how they cope with the challenging situation. This type of research will also continue throughout the coming winter season.


'/>"/>

Contact: Markus Bauer
markus.bauer@esa.int
31-715-656-799
European Space Agency
Source:Eurekalert

Related medicine news :

1. MSU engineering team designs innovative medical device
2. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
3. Providence St. Joseph Medical Center, Caregivers Reach Agreement on a Union Contract
4. Owner and Operator of Florida Durable Medical Equipment Company Convicted of Medicare Fraud
5. Father and Daughter From Tanzania Receive Their First Medical Examination in Newport Beach
6. Doctors and medical ethicist discuss whether doctors should participate in capital punishment
7. Preparation for Natural Disasters Critical for People With Diabetes, Chronic Medical Conditions
8. Doctors and Medical Ethicist Discuss Whether Doctors Should Participate in Capital Punishment
9. Symmetry Medical Completes Acquisition Of Specialty Surgical Instruments
10. Milestone Scientific Announces Successful Completion of its Collaboration Agreement With Carticept Medical
11. FDA Seeks to Regulate Complementary and Alternative Medicine; Products Such as Vegetable Juice Could Be Restricted for Medical Use
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... Angeles, CA (PRWEB) , ... February 10, 2016 ... ... Programming (NLP) practitioner, is known locally for a series of therapeutic sessions to ... in-the-moment in their characters and in their lives. The series, known as “Mindfulness ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... unveiling its revolutionary new 2.0 version at the International Roofing Expo in Orlando, ... power of the world's most advanced weather technology in the hands of consumers, ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... master charity program created to assist the local community. Pledging to select a ... and nonprofit organizations in the area. Their goal is to bring community awareness ...
(Date:2/10/2016)... ... ... Ongoing news of the ravages of traumatic brain injury (TBI) among former ... takes a closer look at cases of TBI being managed by their members. The ... the aging population, and identifies the challenges associated with their care. , During the ...
(Date:2/10/2016)... ... February 10, 2016 , ... Armune BioScience signed a ... network of laboratory service centers across the country. Launched in April of 2015, Apifiny ... detection of prostate cancer. Apifiny order volume exceeded 3,000 tests in 2015. Primary care ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... -- Mast Therapeutics, Inc. (NYSE MKT: MSTX), ... cell disease and heart failure, today announced the pricing ... a price to the public of $0.275 per unit. ... common stock and one warrant to purchase one share ... of $0.42 per share. The warrants are exercisable six ...
(Date:2/10/2016)... Feb. 10, 2016  Silicon Biosystems Menarini Inc., ... that help uncover the biological complexities of disease ... a developer of innovative technologies for genomics research, ... aimed at enabling translational researchers to obtain high-quality ... hundred tumor and normal cells in an optimized ...
(Date:2/10/2016)... Feb. 9, 2016 CTI BioPharma Corp. ... an update regarding the clinical studies being conducted ... for pacritinib. Following the issuance of the Company,s ... clinical hold issued by the U.S. Food and ... Company received an oral communication from the FDA ...
Breaking Medicine Technology: